why choose us

First received: March 27, 2023

Clinical Trial: A Study of PER-001 in Participants With Open-Angle Glaucoma

Study Status: Completed

Recruit Status: RECRUITING

Condition: Open-angle Glaucoma

Study Type: INTERVENTIONAL


Official Title: A Phase 1/2a Study to Evaluate Safety, Tolerability, and Pharmacodynamic Effect After Single Administration of PER-001 Intravitreal Implant in Participants With Open-Angle Glaucoma

Brief Summary: This clinical study has two phases: Phase 1 and Phase 2a.Phase 1 is an open-label, single ascending dose (SAD), while Phase 2a is a randomized, single-masked (participant) with a sham control.

Read more